Best Treatment for Depression: Therapy, Medication, and Beyond

If you or someone you love is living with depression, the sheer number of treatment options can feel overwhelming. Should you start with therapy? Medication? Both? What about newer options like TMS or ketamine?

The good news: approximately 80-90% of people with depression eventually respond well to treatment. The challenge is finding the right treatment — or combination of treatments — for your specific situation.

This guide breaks down every major evidence-based treatment for depression, compares their effectiveness, and helps you understand when each approach makes the most sense.

Psychotherapy

Talk therapy remains one of the most effective treatments for depression, particularly for mild-to-moderate cases. Several types have strong research support.

Cognitive Behavioral Therapy (CBT)

CBT is the most studied psychotherapy for depression. It works by helping you identify and change negative thought patterns and behaviors that maintain depressive symptoms.

• How it works: You learn to recognize distorted thinking (like catastrophizing or black-and-white thinking), test those thoughts against reality, and develop healthier cognitive patterns.
• Effectiveness: Meta-analyses consistently show CBT is as effective as antidepressant medication for mild-to-moderate depression. A key advantage: CBT's benefits tend to last after treatment ends, with lower relapse rates than medication alone.
• Duration: Typically 12-20 weekly sessions, though some people benefit from fewer.
• Best for: Mild-to-moderate depression, people who prefer non-medication approaches, prevention of relapse.

Interpersonal Therapy (IPT)

IPT focuses on improving your relationships and communication patterns, based on the principle that depression often stems from or is worsened by interpersonal problems.

• How it works: You work on specific interpersonal issues — grief, role transitions, conflicts, or social isolation — that contribute to your depression.
• Effectiveness: Comparable to CBT in clinical trials. Especially effective when depression is triggered by relationship problems or major life changes.
• Duration: Usually 12-16 sessions.
• Best for: Depression related to grief, divorce, career change, or relationship conflict.

Behavioral Activation (BA)

BA takes a different approach: instead of focusing on thoughts, it targets the withdrawal and avoidance behaviors that keep depression going.

• How it works: You gradually increase engagement in meaningful activities, even when you don't feel like it. The principle is that action precedes motivation, not the other way around.
• Effectiveness: A 2016 Lancet study found BA was as effective as CBT for major depression, including severe cases, and could be delivered by less specialized therapists.
• Best for: People who respond better to action-oriented approaches, settings with limited access to CBT-trained therapists.

Antidepressant Medications

Antidepressants are first-line treatment for moderate-to-severe depression. They work by altering the balance of neurotransmitters — primarily serotonin, norepinephrine, and dopamine — in the brain.

SSRIs (Selective Serotonin Reuptake Inhibitors)

SSRIs are the most commonly prescribed antidepressants and are typically the first medication tried due to their relatively mild side effect profile.

• Common SSRIs: Sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), paroxetine (Paxil), citalopram (Celexa)
• How they work: Block the reabsorption of serotonin in the brain, making more serotonin available to nerve cells.
• Effectiveness: Response rates of approximately 50-60% in clinical trials. A 2018 Lancet meta-analysis of 522 trials found all 21 antidepressants studied were more effective than placebo.
• Common side effects: Nausea, sexual dysfunction, weight changes, insomnia or drowsiness.
• Timeline: 4-6 weeks for full effect; some improvement in sleep and appetite within 1-2 weeks.

SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

SNRIs act on both serotonin and norepinephrine, potentially offering broader symptom coverage.

• Common SNRIs: Venlafaxine (Effexor), duloxetine (Cymbalta), desvenlafaxine (Pristiq)
• Effectiveness: Comparable to SSRIs overall. May have a slight edge for severe depression and depression with co-occurring chronic pain.
• Side effects: Similar to SSRIs plus possible blood pressure elevation (especially venlafaxine at higher doses).
• Best for: Depression with comorbid pain conditions, patients who haven't responded to SSRIs.

Other Antidepressants

• Bupropion (Wellbutrin): An NDRI that works on norepinephrine and dopamine. Lower risk of sexual side effects and weight gain. Often used for depression with fatigue or low motivation. Also helps with smoking cessation.
• Mirtazapine (Remeron): Works on norepinephrine and serotonin through a different mechanism. Causes sedation and appetite increase — can be helpful for depression with insomnia and weight loss.
• Tricyclics (TCAs): Older medications (amitriptyline, nortriptyline) that are effective but have more side effects. Usually reserved for treatment-resistant cases.
• MAOIs: Monoamine oxidase inhibitors (phenelzine, tranylcypromine) are highly effective but require dietary restrictions. Rarely prescribed as first-line treatment.

Combination Therapy: The Gold Standard

For moderate-to-severe depression, research consistently shows that combining psychotherapy and medication produces the best outcomes.

A landmark study by Keller et al., published in the New England Journal of Medicine, found that combination treatment with nefazodone and CBT achieved a remission rate of 73%, compared to 48% for medication alone and 52% for therapy alone in chronic depression.

The STAR*D trial — the largest real-world depression treatment study ever conducted by the NIMH — found that while only about one-third of patients remitted with initial SSRI monotherapy, adding CBT or switching strategies could bring cumulative remission rates above 60% over multiple treatment steps.

Why combination works better:

• Medication addresses the biological symptoms (sleep, appetite, energy, concentration) faster
• Therapy addresses the cognitive and behavioral patterns that maintain depression
• Therapy provides skills that reduce relapse risk after medication is discontinued
• Together, they cover more of the complex factors that drive depression

Treatment Comparison Table

Treatment	Best For	Response Rate	Time to Effect	Key Consideration
CBT	Mild-to-moderate depression	50-60%	6-12 weeks	Lasting benefits; lower relapse
SSRIs	Moderate-to-severe depression	50-60%	4-6 weeks	Sexual side effects common
SNRIs	Depression with chronic pain	50-60%	4-6 weeks	Monitor blood pressure
Bupropion	Depression with fatigue, low motivation	50-55%	4-6 weeks	Lower sexual side effects
Combination (med + therapy)	Moderate-to-severe; chronic depression	60-73%	6-12 weeks	Best outcomes overall
Exercise	Mild depression; adjunct for all severity	Varies	4-8 weeks	Not sole treatment for moderate-severe
TMS	Treatment-resistant depression	50-60%	4-6 weeks	Requires failed medication trial
Ketamine/Esketamine	Treatment-resistant; acute suicidality	50-70%	Hours to days	Short-term relief; needs maintenance

Exercise as Treatment

Exercise has moved beyond the category of "lifestyle recommendation" into a legitimate evidence-based treatment for depression.

A 2023 umbrella review published in the British Journal of Sports Medicine analyzed 97 systematic reviews covering over 128,000 participants and concluded that physical activity is 1.5 times more effective than counseling or leading medications for reducing symptoms of depression.

What the evidence supports:

• Type: Aerobic exercise (walking, running, cycling, swimming) shows the strongest evidence. Resistance training also shows significant benefits.
• Dose: 150 minutes per week of moderate-intensity exercise, or 75 minutes of vigorous exercise. Even sub-threshold amounts show benefit.
• Mechanism: Exercise increases BDNF (brain-derived neurotrophic factor), reduces inflammation, improves sleep, and promotes neuroplasticity.

Important caveat: Exercise is not a substitute for professional treatment in moderate-to-severe depression. It works best as part of a comprehensive treatment plan.

Brain Stimulation Therapies

Transcranial Magnetic Stimulation (TMS)

TMS is an FDA-cleared treatment for depression that uses magnetic pulses to stimulate nerve cells in the left dorsolateral prefrontal cortex — a region associated with mood regulation.

• How it works: A magnetic coil placed against the scalp delivers brief magnetic pulses that stimulate neurons. It's non-invasive and doesn't require anesthesia.
• Effectiveness: In treatment-resistant depression, response rates range from 50-60%, with remission rates of approximately 30%. Stanford's SAINT protocol (accelerated TMS) showed 79% remission rates in a small 2022 trial.
• Treatment course: Standard protocol involves 5 sessions per week for 4-6 weeks. Accelerated protocols can compress this into 5 days.
• Side effects: Generally mild — scalp discomfort and headache are most common. Very small risk of seizure (~0.01%).
• Best for: Patients who haven't responded to at least one adequate medication trial.

Electroconvulsive Therapy (ECT)

ECT remains the most effective acute treatment for severe depression, particularly when rapid response is needed.

• Effectiveness: Remission rates of 50-65% even in treatment-resistant cases — higher than any other single intervention.
• Best for: Severe depression with psychotic features, acute suicidality, catatonia, or when multiple medication trials have failed.
• Side effects: Short-term memory loss is the primary concern. Modern techniques (brief-pulse, right unilateral placement) have significantly reduced cognitive effects.

Ketamine and Esketamine

Ketamine-based treatments represent the most significant advance in depression treatment in decades due to their rapid onset of action.

• Esketamine (Spravato): FDA-approved nasal spray for treatment-resistant depression. Must be administered in a certified healthcare setting with a 2-hour monitoring period.
• IV Ketamine: Administered off-label in specialized clinics. Some patients report improvement within hours.
• Limitation: Effects are often temporary (days to weeks), requiring ongoing maintenance treatments. Long-term safety data is still accumulating.

How to Choose the Right Treatment

The best treatment depends on several factors specific to you:

• Severity: Mild depression often responds to therapy alone. Moderate-to-severe depression typically benefits from medication, ideally combined with therapy.
• Previous treatment history: What's worked or failed before guides next steps. Treatment-resistant depression may warrant TMS, ketamine, or ECT.
• Co-occurring conditions: Anxiety, chronic pain, ADHD, or substance use can influence which treatments are most appropriate.
• Side effect concerns: Worry about sexual side effects? Bupropion may be better than SSRIs. Struggling with insomnia? Mirtazapine might help both depression and sleep.
• Preference and access: Therapy requires time and access to a trained therapist. Medication requires prescriber follow-up. TMS requires daily clinic visits for several weeks. Online therapy platforms like Brightside can improve access for some people.
• Speed of response needed: If you're in crisis, medication or ketamine can provide faster relief than therapy alone.